While we’re making comparisons most CEO’s donâ

While we’re making comparisons most CEO’s don’t rescue a drug that could Soon be worth 100’s billions dollars with 20+ cancer indications , HIV, Nash, and Covid that would have been shelved and buried. Ide love to see an approval already and some many might argue that we should have had an EUA with 100’s millions in sales already have the fda acted fairly.